A detailed history of State Of Alaska, Department Of Revenue transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 21,667 shares of AMPH stock, worth $956,814. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,667
Previous 22,395 3.25%
Holding current value
$956,814
Previous $895,000 17.43%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$36.99 - $50.09 $26,928 - $36,465
-728 Reduced 3.25%
21,667 $1.05 Million
Q2 2024

Aug 05, 2024

SELL
$38.65 - $43.48 $14,261 - $16,044
-369 Reduced 1.62%
22,395 $895,000
Q1 2024

Apr 19, 2024

SELL
$42.85 - $63.45 $9,641 - $14,276
-225 Reduced 0.98%
22,764 $999,000
Q4 2023

Jan 19, 2024

SELL
$44.49 - $62.93 $32,833 - $46,442
-738 Reduced 3.11%
22,989 $1.42 Million
Q3 2023

Oct 16, 2023

SELL
$45.51 - $65.0 $46,966 - $67,080
-1,032 Reduced 4.17%
23,727 $1.09 Million
Q2 2023

Jul 24, 2023

SELL
$35.77 - $58.38 $37,773 - $61,649
-1,056 Reduced 4.09%
24,759 $1.42 Million
Q1 2023

Apr 17, 2023

SELL
$27.99 - $37.92 $9,880 - $13,385
-353 Reduced 1.35%
25,815 $968,000
Q4 2022

Jan 11, 2023

SELL
$27.93 - $31.27 $8,406 - $9,412
-301 Reduced 1.14%
26,168 $733,000
Q3 2022

Oct 20, 2022

SELL
$27.56 - $37.75 $54,265 - $74,329
-1,969 Reduced 6.92%
26,469 $743,000
Q2 2022

Jul 08, 2022

BUY
$29.79 - $42.29 $83,709 - $118,834
2,810 Added 10.96%
28,438 $989,000
Q1 2022

Apr 14, 2022

SELL
$22.96 - $36.45 $9,758 - $15,491
-425 Reduced 1.63%
25,628 $920,000
Q4 2021

Jan 12, 2022

SELL
$18.14 - $23.29 $16,779 - $21,543
-925 Reduced 3.43%
26,053 $606,000
Q3 2021

Oct 07, 2021

BUY
$17.83 - $21.49 $28,527 - $34,384
1,600 Added 6.3%
26,978 $512,000
Q2 2021

Jul 12, 2021

BUY
$17.11 - $20.92 $10,488 - $12,823
613 Added 2.48%
25,378 $511,000
Q1 2021

Apr 09, 2021

SELL
$17.21 - $20.65 $63,677 - $76,405
-3,700 Reduced 13.0%
24,765 $453,000
Q4 2020

Jan 08, 2021

SELL
$17.76 - $21.24 $101,942 - $121,917
-5,740 Reduced 16.78%
28,465 $572,000
Q3 2020

Oct 05, 2020

BUY
$17.99 - $22.22 $43,175 - $53,328
2,400 Added 7.55%
34,205 $641,000
Q2 2020

Jul 06, 2020

BUY
$14.25 - $22.46 $285 - $449
20 Added 0.06%
31,805 $714,000
Q1 2020

Apr 06, 2020

BUY
$12.66 - $20.08 $74,883 - $118,773
5,915 Added 22.86%
31,785 $471,000
Q4 2019

Jan 07, 2020

SELL
$17.07 - $20.64 $10,498 - $12,693
-615 Reduced 2.32%
25,870 $499,000
Q3 2019

Oct 02, 2019

BUY
$19.12 - $22.62 $277,087 - $327,809
14,492 Added 120.84%
26,485 $525,000
Q2 2019

Jul 23, 2019

BUY
$18.92 - $22.96 $6,546 - $7,944
346 Added 2.97%
11,993 $253,000
Q1 2019

Apr 09, 2019

BUY
$19.46 - $25.28 $1,362 - $1,769
70 Added 0.6%
11,647 $237,000
Q4 2018

Jan 10, 2019

SELL
$17.72 - $22.51 $4,518 - $5,740
-255 Reduced 2.16%
11,577 $230,000
Q3 2018

Oct 09, 2018

BUY
$15.39 - $19.38 $1,539 - $1,938
100 Added 0.85%
11,832 $227,000
Q2 2018

Jul 10, 2018

BUY
$14.63 - $19.6 $4,974 - $6,664
340 Added 2.98%
11,732 $179,000
Q1 2018

Apr 19, 2018

BUY
$17.23 - $20.35 $74,778 - $88,319
4,340 Added 61.54%
11,392 $213,000
Q3 2017

Oct 16, 2017

BUY
$14.73 - $17.99 $103,875 - $126,865
7,052
7,052 $126,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.16B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.